Blue-Chip

2 Blue-chip Stocks to Buy – SCG, WBC

March 07, 2019 | Team Kalkine
2 Blue-chip Stocks to Buy – SCG, WBC

 

Scentre Group


SCG Details

“A Stable” Rating by Fitch: Scentre Group (ASX: SCG) has recently disclosed that the ensuing AGM shall be held on Thursday, 4 April 2019 and would start at 10:00 AM. The business of the meeting revolves around considering the group’s 2018 financial statements as well as reports, the remuneration report and the election of Directors. The company added that Mr. Steven Lowy would be retiring at the end of AGM.
 
The company has recently been assigned an ‘A Stable’ credit rating by Fitch. This rating was assigned bearing in mind the company’s leading asset portfolio and exclusive operating platform as well as the group’s consistency of income and robust financial position.
 
As per the results released for the 12 months period which ended on 31 December 2018, the firm posted funds from operations (“FFO”) of $1.34 Bn resulting into 25.24 cents per security, implying a rise of 3.9%. The company announced a distribution of 22.16 cents per security implying a 2% rise. The growth in FFO was achieved on account of the surge witnessed in the net operating income as well as the project income reflecting the quality of the firm’s platform and its strategic execution of stated plans.
 
What to Expect From SCG: Going forth, the group forecasts the FFO growth for the 12 months ending 31 December 2019 of approximately 3%.The distribution for 2019 is anticipated to be 22.60 cents per security.
 

SCG’s specialty In-Store sales growth (In %) (Source: Company Reports)
 
On the financial metrics front, the company has been able to efficiently manage its debt profile which is evident from the interest coverage of 3.5x and gearing of 33.9%. Meanwhile, the share price has fallen 5.77% in the past six months (as at 05 March 2019) and is trading close to a 52-week lower level, showing an excellent opportunity for the investors to acquire the stock at these levels.Thus, considering the stable income, strong occupancy at 99.3% along with optimization of debt profile, and decent FFO growth guidance for FY19, we maintain our “Buy” rating on the stock at the current market price of $3.950 per share (up 0.765% on 6 March 2019).


SCG Daily Chart (Source: Thomson Reuters)
 

Westpac Banking Corporation


WBC Details
 
Increasing Productivity Target: Westpac Banking Corporation (ASX: WBC) disclosed that the management has lifted the group’s productivity target for the next year to $400 million as the bank continue to simplify its products, digitise its business, and modernise its platforms. The management is committed to devote funds in technology to improve the quality of services to customers and make it easier for them to do business with the bank. The management has a confidence that its service-led strategy remains the finest way to generate value for its shareholders. On the other hand, the company has recently announced the interim distribution of $0.3300 per security for SFI (Self-Funding Instalments) over securities in Sonic Healthcare Limited (SHL) as mentioned in PDS (Product Disclosure Statement) and dividends will be applied to reduce the Completion Payment of the SFIs and will be paid On or about 26 March 2019 with the ex-distribution/ entitlement date of 08 March 2019 and record date of 11 March 2019.This distribution shall be 20% franked.
 

WBC’s Total shareholder return and ROE (Source: Company Reports)
 
The stock price has fallen by 3.33% over the past six months (as at March 05, 2019) and is trading at reasonable PE level of 11.37x.Hence, considering the decent outlook, strong dividend yield of around 6.96% and robust fundamentals, we maintain our “Buy” recommendation on the stock at the current market price of $27.250 per share (up 0.889% on 6 March 2019).


WBC Daily Chart (Source: Thomson Reuters) 


Disclaimer
 
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.